# Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City

> **NCT02382900** · PHASE3 · UNKNOWN · sponsor: **Universidad Nacional Autonoma de Mexico** · enrollment: 500 (estimated)

## Conditions studied

- Human Papilloma Virus

## Interventions

- **BIOLOGICAL:** quadrivalent human papillomavirus (types 6, 11, 16,18) recombinant vaccine

## Key facts

- **NCT ID:** NCT02382900
- **Lead sponsor:** Universidad Nacional Autonoma de Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-02
- **Primary completion:** 2015-10
- **Final completion:** 2015-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2015-03-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02382900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02382900, "Two-dose Schedule of Quadrivalent HPV Recombinant Vaccine in 11-year-old Boys in Mexico City". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02382900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*